CABG boosts outcomes in diabetes plus multivessel CAD

11/4/2012 | Healio

Data on 1,900 patients with diabetes and multivessel coronary artery disease showed those who underwent coronary artery bypass grafting had lower rates of all-cause mortality, nonfatal myocardial infarction or nonfatal stroke at five years compared with those who had percutaneous coronary intervention with a drug-eluting stent. Lower rates of cardiovascular and cerebrovascular events were also seen in the CABG group, researchers said. The results were presented at the American Heart Association meeting.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI